Jaguar Health, Inc.
JAGX
$10.91
-$0.83-7.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.67% | -3.81% | -2.88% | -0.61% | -17.90% |
| Total Depreciation and Amortization | -0.50% | 6.62% | -8.36% | 3.21% | -5.44% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -83.98% | -75.87% |
| Total Other Non-Cash Items | -5.01% | 54.52% | 38.33% | -47.27% | 343.22% |
| Change in Net Operating Assets | -708.43% | 85.65% | -710.46% | 95.40% | 40.52% |
| Cash from Operations | -23.42% | 22.39% | -15.94% | 5.42% | -9.73% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 22.62% | -135.11% | 57.66% | 63.61% | -- |
| Issuance of Common Stock | -19.58% | -70.40% | 1.62% | 24.29% | 605.60% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -66.67% | 73.13% | -59.52% | -103.57% | 5,985.00% |
| Cash from Financing | -19.83% | -71.93% | 2.49% | 15.19% | 655.86% |
| Foreign Exchange rate Adjustments | -280.65% | 410.00% | 47.37% | -143.18% | 320.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -89.46% | -163.50% | -15.84% | 60.41% | 160.04% |